Stephan Reichenbach

机构：Institute of Social and Preventive Medicine · ORCID：0000-0001-8098-6567

发表论文 165 篇 · 总被引 15061 次 · h-index 54

代表论文

• Risk of Osteonecrosis of the Jaw Under Denosumab Compared to Bisphosphonates in Patients With Osteoporosis (2020 · Journal of Bone and Mineral Research · 被引 107)
• Tocilizumab monotherapy after ultra-short glucocorticoid administration in giant cell arteritis: a single-arm, open-label, proof-of-concept study (2021 · The Lancet Rheumatology · 被引 71)
• Multi-centre randomised controlled trial comparing arthroscopic hip surgery to physiotherapist-led care for femoroacetabular impingement (FAI) syndrome on hip cartilage metabolism: the Australian FASHIoN trial (2021 · BMC Musculoskeletal Disorders · 被引 69)
• Quantitative ultrasound to monitor the vascular response to tocilizumab in giant cell arteritis (2021 · Lara D. Veeken · 被引 63)
• Risk factors for vertebral fractures and bone loss after denosumab discontinuation: A real-world observational study (2020 · Bone · 被引 60)
• Effect of transcutaneous electrical nerve stimulation (TENS) on knee pain and physical function in patients with symptomatic knee osteoarthritis: the ETRELKA randomized clinical trial (2021 · Osteoarthritis and Cartilage · 被引 53)